A nomogram for predicting survival of patients with locally advanced pancreatic cancer treated with chemoradiotherapy.

CONCLUSION: A nomogram was developed with high-dose radiation (EQD2, ≥61 Gy), initial SUVmax <3.5, CA 19-9 ≤400 U/mL, and surgical resection after CRT for patients with LAPC. This will help in clinical decision-making and in selecting patients for CRT. PMID: 30177371 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30177371?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - August 31, 2018 Category: Radiology Authors: Choi SH, Park SW, Seong J Tags: Radiother Oncol Source Type: research